Aciphex rabeprazole sodium
Aciphex rabeprazole sodium
Daily treatment with gastric acid-suppressing medication such as rabeprazole over a long period of time (e. [12] This effect is beneficial for the treatment and prevention of conditions in which gastric acid directly worsens symptoms, such as duodenal and gastric ulcers. lipitor 10mg tablet Select Safety Information for ACIPHEX® (rabeprazole sodium) delayed-release tablets. Rabeprazole sodium is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. Peak plasma concentrations occur over a range of 2 to 5 hours WOODCLIFF LAKE, N. : 020973 Approval Date: 8/19/1999. The rabeprazole Cmax and AUC are linear over an. The most common side effect possibly related to ACIPHEX® is headache. Inactive ingredients of the 20 mg tablet are carnauba wax, crospovidone, diacetylated monoglycerides, ethylcellulose, hydroxypropyl cellulose, hypromellose phthalate, magnesium stearate, mannitol, sodium hydroxide, sodium stearyl fumarate, talc, and titanium dioxide WOODCLIFF LAKE, N. RABEPRAZOLE/Aciphex (ra BE pray zole) treats heartburn, stomach ulcers, reflux disease, or other conditions caused by too much stomach acid. ACIPHEX is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of aciphex rabeprazole sodium rabeprazole sodium. , > 3 years) may lead to malabsorption of cyanocobalamin and vitamin B12 deficiency. The “Discontinued Drug Product List” delineates, among other items, drug products that have been discontinued from marketing for reasons other than safety or effectiveness Skip to Main Content; U. Patients should disclose any medications, such as Methotrexate or Warfarin, that they are taking before taking ACIPHEX, as ACIPHEX can affect how certain oral medications work in the body.. Inactive ingredients of the 20 mg tablet are carnauba wax, crospovidone, diacetylated monoglycerides, ethylcellulose, hydroxypropyl cellulose, hypromellose phthalate, magnesium stearate, mannitol, propylene glycol, sodium hydroxide, sodium stearyl fumarate, talc, and. The absolute bioavailability of rabeprazole is about 52%. Patients on warfarin or other medications may need to be monitored more. , March 26, 2013 / PRNewswire / -- Eisai Inc. AcipHex tablets are used to treat:. ACIPHEX (rabeprazole sodium) should not be taken by patients who are allergic to rabeprazole sodium or any of its ingredients. The structural formula is: RABEPRAZOLE SODIUM ACIPHEX® is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium aciphex. Rabeprazole is a gastric proton-pump inhibitor. Cases of cyanocobalamin deficiency occurring with acid-suppression therapy have been reported in the literature ACIPHEX is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium. This medicine may raise the chance of hip, spine, and wrist fractures in people with weak bones ( osteoporosis ). Accordingly, the agency will continue to list ACIPHEX (rabeprazole sodium) delayed-release tablets, 10 mg, in the “Discontinued Drug Product List” section of the Orange Book. Rabeprazole | C18H21N3O3S | CID 5029 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety. It belongs to a group of medications called PPIs. The “Discontinued Drug Product List” delineates, among other items, drug products that have been discontinued from marketing for reasons other than safety or effectiveness rabeprazole sodium is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. Rabeprazole delayed-release tablets are enteric-coated to allow rabeprazole sodium, which is acid labile, to pass through the stomach relatively intact.